CVI Accepts, published online ahead of print on 18 March 2009
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Thibodeaux, B. A.
Right arrow Articles by Roehrig, J. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Thibodeaux, B. A.
Right arrow Articles by Roehrig, J. T.

 Previous Article  |  Next Article 

Clin. Vaccine Immunol. doi:10.1128/CVI.00354-08
Copyright (c) 2009, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

Development of a human-murine chimeric immunoglobulin M for use in the serological detection of human flavivirus antibodies

Brett A. Thibodeaux and John T. Roehrig*

Arboviral Diseases Branch, Division of Vector-Borne Infectious Diseases, National Center for Zoonotic, Vector-Borne and Enteric Diseases, Coordinating Center for Infectious Diseases, Centers for Disease Control and Prevention, U.S. Department of Health and Human Services, 3150 Rampart Road, Fort Collins, CO 80521

* To whom correspondence should be addressed. Email: jtr1{at}cdc.gov.


arrow
Abstract

Current diagnosis of human flaviviral infections relies heavily on serological techniques such as the immunoglobulin (Ig) M antibody capture enzyme-linked immunosorbent assay (MAC-ELISA). Broad application of this assay is hindered by the lack of standardized positive human control sera that react with the wide variety of flaviviruses that can cause human disease, e.g., dengue (DEN), West Nile (WN), yellow fever (YF), Japanese encephalitis (JE), and Saint Louis encephalitis virus (SLEV). We have created a human-murine chimeric antibody combining the variable regions of a broadly flavivirus cross-reactive murine monoclonal antibody (MAb) 6B6C-1, and the constant region of human IgM to produce a standardized reagent capable of replacing human positive control sera in MAC-ELISA for diagnosis of all human flaviviral infections. Human-murine chimeric IgM antibody secreted from plasmid transformed Sp2/0-Ag14 cells had serological activity identical to 6B6C-1 as measured in ELISA, immunoblotting, and MAC-ELISA for multiple members of the flavivirus genus, including WNV, SLEV, YFV, DENV and JEV.